Department of Experimental and Health Sciences, Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra, 08005 Barcelona, Spain.
Department of In formation and Communication Technologies, Universitat Pompeu Fabra, 08018 Barcelona, Spain.
Biosensors (Basel). 2024 Aug 8;14(8):382. doi: 10.3390/bios14080382.
This study evaluated electrical conductivity in human liver tissue in the 3-1000 kHz frequency range to compare normal versus tumor tissues under in vivo versus ex vivo conditions.
Previous informed consent was obtained from twenty patients undergoing liver resection in whom liver electrical conductivity was measured during surgery and after resection.
We found higher electrical conductivity values in tumor tissues than in normal tissue in both in vivo (0.41 ± 0.10 vs. 0.13 ± 0.06 S/m) and ex vivo (0.27 ± 0.09 vs. 0.12 ± 0.07 S/m) conditions (at 3 kHz). The electric properties also showed a promising potential for distinguishing between different tissue types including metastasis, cholangiocarcinoma (CCA), hepatocellular carcinoma (HCC), hepatic cirrhosis, and normal liver (both in vivo and ex vivo). At 3 kHz, in vivo electrical conductivity for cholangiocarcinoma, HCC, and metastasis were 0.35, 0.42 ± 0.13, and 0.41 ± 0.08 S/m, respectively, which differed significantly from each other ( < 0.05).
These findings could potentially improve liver disease diagnostics through electrical conductivity measurements and treatment techniques involving electric fields. Future research should focus on expanding the sample size to refine the categorization and comparison processes across diverse human liver tissue types.
本研究评估了人类肝脏组织在 3-1000 kHz 频率范围内的电导率,以比较体内和体外条件下正常组织与肿瘤组织的电导率。
先前已获得二十名接受肝切除术患者的知情同意,在手术中和切除后测量了他们的肝电导率。
我们发现,在体内(3 kHz 时为 0.41 ± 0.10 比 0.13 ± 0.06 S/m)和体外(0.27 ± 0.09 比 0.12 ± 0.07 S/m)条件下,肿瘤组织的电导率值均高于正常组织。这些电特性也显示出有潜力区分不同的组织类型,包括转移、胆管癌(CCA)、肝细胞癌(HCC)、肝硬变和正常肝(体内和体外)。在 3 kHz 时,胆管癌、HCC 和转移的体内电导率分别为 0.35、0.42 ± 0.13 和 0.41 ± 0.08 S/m,彼此之间差异显著(<0.05)。
这些发现可能通过电导率测量和涉及电场的治疗技术来改善肝脏疾病的诊断。未来的研究应着眼于扩大样本量,以完善不同人类肝组织类型的分类和比较过程。